Showing 201-210 of 3173 results for "".
- Special Report: An Overview of Coronavirus by Dr. Jonathan Kaplanhttps://practicaldermatology.com/news/special-report-an-overview-of-coronavirus-by-dr-jonathan-kaplan/2460306/Wash your hands, wipe down surfaces, don’t touch your face, and practice social distancing. If nothing else, that’s what you should take away from this coronavirus overview. But keep reading to learn important details about this epidemic. Such as, how we can make it end with less collateral damage?…
- Maternal Depression Linked to AD in Kidshttps://practicaldermatology.com/news/maternal-depression-linked-to-ad-in-kids/2460257/Maternal depression in the postpartum period, and even beyond, is associated with the development of atopic dermatitis (AD) throughout childhood and adolescence, according to a recent study published in the journal Dermatitis. The study, led by Jonathan Silverberg, MD, PhD, MPH, associate professo…
- CSF Kicks Off in Nashvillehttps://practicaldermatology.com/news/csf-kicks-off-in-nashville/2460229/Cosmetic Surgery Forum (CSF), now in its 11th year, has kicked off in Nashville. It’s the meeting’s first time in the Music City, which allows for live injection sessions—a popular meeting highlight. The program covers everything from cannabidiol (CBD) in skincare and platelet-rich plasma (PRP) for…
- Keloid Breakthrough: Mount Sinai Researchers Show Keloid Shrinkage with Dupilumabhttps://practicaldermatology.com/news/keloid-breakthrough-mount-sinai-researchers-show-keloid-shrinkage-with-dupilumab/2460223/Keloid lesions exhibit increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy, Mount Sinai researchers report. Researchers, led by Emma Guttman-Yassky, MD, PhD, Vice Chair, Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, presented a case…
- Kylie Jenner Sells $600 Million Majority Stake in Beauty Business to Cotyhttps://practicaldermatology.com/news/kylie-jenner-sells-600-million-majority-stake-in-beauty-business-to-coty/2460220/Kylie Jenner sold a majority stake in Kylie Cosmetics and Kylie Skin to Coty Inc. Under the terms of the agreement, Coty will acquire a 51 percent ownership in the partnership for $600M. The acquisition is expected to close in the third quarter of fiscal year 2020. Coty's family of brands includes…
- National Emsculpt Week Kicks Offhttps://practicaldermatology.com/news/national-emsculpt-week-kicks-off/2460033/BTL has proclaimed the week of May 20 "National Emsculpt Week," in honor of the first and only non-invasive treatment to go beyond the elimination of fat cells to strengthen and define muscles. National Emsculpt Week was just registered with the National Day Calendar organization, giving physician …
- Kamedis: Clinical Study Validates Traditional Chinese Botanical for Eczemahttps://practicaldermatology.com/news/kamedis-clinical-study-validates-traditional-chinese-botanical-for-eczema/2460020/Traditional Chinese botanicals in homeopathic over-the-counter Kamedis Calm Eczema Therapy Cream play a pivotal role in the product’s ability to reduce eczema rashes, according to results of a new study announced by the company. Results show that commercially available Kamedis cream was 44% mor…
- Crown Labs Adds to Portfolio with Acquisition of Keri from GSKhttps://practicaldermatology.com/news/crown-labs-adds-to-portfolio-with-acquisition-of-keri-from-gsk/2460017/Crown Laboratories, Inc. acquired the North American rights for Keri from GlaxoSmithKline (GSK). The acquisition of Keri from GSK marks the sixth product from GSK that Crown has acquired in the past five months. “Acquiring the Keri brand supports Crown’s objective of providing its customers with …
- Almirall: Positive Data for KX2-391 for AKs; ThermiGen to be Divestedhttps://practicaldermatology.com/news/almirall-positive-data-for-kx2-391-for-aks-thermigen-to-be-divested/2459986/Results from two Phase III studies of KX2-391, also known as KX-01 ointment, in the treatment of actinic keratosis show positive results. The findings have been presented at the 2019 American Academy of Dermatology Annual Meeting in Washington, DC and were reported by Almirall, SA and Athenex, Inc…
- New Guidelines Offer SRT Treatment Recommendations for Skin Cancers, Keloidshttps://practicaldermatology.com/news/new-guidelines-offer-srt-treatment-recommendations-for-skin-cancers-keloids/2459897/Superficial Radiation Therapy (SRT) should be first-line therapy for appropriate non-melanoma skin cancers in appropriate patients, according to new consensus guidelines published in The Journal of Clinical and Aesthetic Dermatology. Appropriate tumor types for SRT include primary basal cell carc…